http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#Head http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#assertion http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#provenance http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#pubinfo http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#assertion http://purl.obolibrary.org/obo/DOID_11330 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11330 http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01053 http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association http://www.w3.org/2000/01/rdf-schema#label to reduce the development of drug resistant bacteria and maintain the effectiveness of penicillin g procaine and other antibacterial drugs penicillin g procaine should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy penicillin g procaine is indicated in the treatment of moderately severe infections in both adults and pediatric patients due to penicillin g susceptible microorganisms that are susceptible to the low and persistent serum levels common to this particular dosage form in the indications listed below therapy should be guided by bacteriological studies including susceptibility tests and by clinical response note when high sustained serum levels are required aqueous penicillin g either im or iv should be used the following infections will usually respond to adequate dosages of intramuscular penicillin g procaine moderately severe to severe infections of the upper respiratory tract skin and soft tissue infections scarlet fever and erysipelas due to susceptible streptococci group a without bacteremia note streptococci in groups a c g h l and m are very sensitive to penicillin g other groups including group d enterococcus are resistant aqueous penicillin is recommended for streptococcal infections with bacteremia moderately severe infections of the respiratory tract due to susceptible pneumococci note severe pneumonia empyema bacteremia pericarditis meningitis peritonitis and arthritis of pneumococcal etiology are better treated with aqueous penicillin g during the acute stage moderately severe infections of the skin and soft tissues due to susceptible staphylococci penicillin g susceptible note reports indicate an increasing number of strains of staphylococci resistant to penicillin g emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections indicated surgical procedures should be performed fusospirochetosis vincent s gingivitis and pharyngitis moderately severe infections of the oropharynx due to susceptible fusiform bacilli and spirochetes note necessary dental care should be accomplished in infections involving the gum tissue syphilis all stages due to susceptible treponema pallidum note this drug should not be used in the treatment of beta lactamase producing organisms which include most strains of neisseria gonorrhea yaws bejel pinta due to susceptible organisms penicillin g procaine is an adjunct to antitoxin for prevention of the carrier stage of diphtheria due to susceptible c diphtheriae anthrax due to bacillus anthracis bacillus anthracis rat bite fever due to susceptible streptobacillus moniliformis spirillum minus erysipeloid due to susceptible erysipelothrix rhusiopathia subacute bacterial endocarditis only in extremely sensitive infections due to susceptible group a streptococci http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01053 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#provenance http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#pubinfo http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig http://purl.org/nanopub/x/hasSignature WPbIy2J/ESQvrY2fcNvs/uLIbjr2FxzUu/aNJE0ytP6lh2prhDsL4UgcwtYTkCQmqDPbSZR64FDDEskv1ohIRW6Z53XwHysQ9E+Dx6aMrK+pVU3qdkFr+lhNdsyvH59ZkwYP6ME20hbmCDIKsf06KQ9p1X+UKxdRxH32KjhganI= http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://purl.org/dc/terms/created 2021-06-13T16:25:32.420+02:00 http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs